Chronic testosterone cypionate therapy in men with secondary impotence
- PMID: 3525237
- DOI: 10.1016/s0015-0282(16)49529-4
Chronic testosterone cypionate therapy in men with secondary impotence
Abstract
There have not been studies assessing the effects of chronic testosterone cypionate (TC) therapy on circulating levels of testosterone (T), estradiol (E2), free T, bioavailable T (BAT), luteinizing hormone (LH), and sexual function in impotent men with low T levels. This study was a double-blind crossover using 200 mg of TC or placebo given intramuscularly every 14 days for six injections and the other medication given for six doses. Blood was drawn before each injection. Mean concentrations of T, E2, free T, and BAT were the same on TC or on placebo, but serum LH was significantly suppressed during intramuscular TC. With TC statistically significant improvements in libido and in potency were noted. Five of the men were able to have vaginal sex while taking TC. TC injections every 14 days do not appear to maintain increased T concentrations for 2 full weeks, and other dosage/injection schedules are being evaluated, but there were improvements in libido and potency.
Similar articles
-
Sexual functioning in testosterone-supplemented patients treated for bilateral testicular cancer.Br J Urol. 1997 Mar;79(3):461-7. doi: 10.1046/j.1464-410x.1997.00027.x. Br J Urol. 1997. PMID: 9117232
-
Effects of androgen treatment in impotent men with normal and low levels of free testosterone.Arch Sex Behav. 1990 Jun;19(3):223-34. doi: 10.1007/BF01541548. Arch Sex Behav. 1990. PMID: 2193636 Clinical Trial.
-
Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.J Clin Endocrinol Metab. 1993 Jul;77(1):290-3. doi: 10.1210/jcem.77.1.8325955. J Clin Endocrinol Metab. 1993. PMID: 8325955
-
Changes in the bioactivity to immunoreactivity ratio of circulating luteinizing hormone in impotent men treated with testosterone undecanoate.Acta Endocrinol (Copenh). 1989 Mar;120(3):284-8. doi: 10.1530/acta.0.1200284. Acta Endocrinol (Copenh). 1989. PMID: 2648724 Clinical Trial.
-
[Testosterone and impotence--when is androgen substitution advisable?].Ther Umsch. 1998 Jun;55(6):372-6. Ther Umsch. 1998. PMID: 9658979 Review. German.
Cited by
-
Testosterone for erectile failure.J Gen Intern Med. 1993 Sep;8(9):517-21. doi: 10.1007/BF02600118. J Gen Intern Med. 1993. PMID: 8410427 No abstract available.
-
Androgen replacement in men with hypogonadism and erectile dysfunction.Endocrine. 2004 Mar-Apr;23(2-3):143-8. doi: 10.1385/ENDO:23:2-3:143. Endocrine. 2004. PMID: 15146093 Review.
-
Relationship between testosterone and erectile dysfunction.Rev Urol. 2000 Spring;2(2):122-8. Rev Urol. 2000. PMID: 16985751 Free PMC article.
-
Treatment of Men for "Low Testosterone": A Systematic Review.PLoS One. 2016 Sep 21;11(9):e0162480. doi: 10.1371/journal.pone.0162480. eCollection 2016. PLoS One. 2016. PMID: 27655114 Free PMC article.
-
Testosterone replacement in men with sexual dysfunction.Cochrane Database Syst Rev. 2024 Jan 15;1(1):CD013071. doi: 10.1002/14651858.CD013071.pub2. Cochrane Database Syst Rev. 2024. PMID: 38224135 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical